LENVIMA is used along with another medicine called everolimus to treat advanced renal cell carcinoma (RCC), a type of kidney cancer, after one course of treatment with another anti-cancer medicine.
Advanced kidney cancer (RCC)
Your path ahead could have another treatment choice
The combination treatment LENVIMA + everolimus was
studied in a clinical trial of 153 people with advanced or
metastatic RCC who were already treated with 1 prior anti-
cancer medicine compared to everolimus alone.
Financial assistance programs are available to help appropriate patients access LENVIMA
Talk to your health care team to find out how you
will receive LENVIMA.